Lazard (NYSE: LAZ), AbbVie (NYSE: ABBV), and NiSource (NYSE: NI) don't have much in common other than they are all U.S. companies that are a little bit underappreciated.

Investment firm Lazard and utility company NiSource are perhaps not as widely known to some investors, so it's not surprising that they might trade below 19 times forward earnings. AbbVie is a large-cap pharmaceutical company that is coming off a phenomenal year, and yet it is trading for less than 12 times forward earnings.

Looking ahead at 2023, there's a lot to like with all three dividend stocks.

Continue reading

Source Fool.com